X

Vous n'êtes pas connecté

Maroc Maroc - NEWS.MEDICAL.NET - A la Une - 17/Jan 07:27

Unveiling the metabolic pathways of Fusobacterium nucleatum in OSCC

A recent study has made significant strides in uncovering how the oral microbiome, particularly the bacterium Fusobacterium nucleatum, plays a crucial role in the progression of oral squamous cell carcinoma (OSCC). By identifying key interactions between this common oral bacterium and host cells, the research has unveiled important metabolic pathways and mechanisms that may serve as potential therapeutic targets.

Articles similaires

Novel biomarker for prognosis and immunotherapy response in head and neck cancer

oncologynews.com.au - 23/Oct 00:44

In a groundbreaking study published in Current Molecular Pharmacology, researchers have identified a novel biomarker for predicting prognosis and...

Making cancer vaccines more personal

oncologynews.com.au - 31/Oct 15:53

In a new study, researchers created a model for cutaneous squamous cell carcinoma, a type of skin cancer, and identified two mutated tumour proteins,...

Early warning signs of stage 0 cancer: Recognising carcinoma in situ in mouth, skin, breast, and more

times of india - 22/Oct 14:30

Stage 0 cancer, known as carcinoma in situ, marks the earliest stage of cancer development. Abnormal cells are present but have not spread. Early...

Sorry! Image not available at this time

Studying Immune Checkpoint Signaling to Fight Cancer

wn.com - 22/Oct 13:24

Cancer cells evade detection and destruction by modulating immune checkpoint signaling. Targeting these pathways to restore immune function can be an...

Sorry! Image not available at this time

Quell Therapeutics to Unveil Promising Data for QEL-005, a Novel CAR-Treg Cell Therapy for Complex Autoimmune Diseases, at ACR Convergence 2025

wn.com - 27/Oct 10:58

Quell Therapeutics to Unveil Promising Data for QEL-005, a Novel CAR-Treg Cell Therapy for Complex Autoimmune Diseases, at ACR Convergence 2025 ...

Sorry! Image not available at this time

Quell Therapeutics to Unveil Promising Data for QEL-005, a Novel CAR-Treg Cell Therapy for Complex Autoimmune Diseases, at ACR Convergence 2025

wn.com - 27/Oct 10:58

Quell Therapeutics to Unveil Promising Data for QEL-005, a Novel CAR-Treg Cell Therapy for Complex Autoimmune Diseases, at ACR Convergence 2025 ...

Sorry! Image not available at this time

Ferrer Completes Recruitment of 220 Patients for the PROSPER Study, a Phase II Clinical Trial in Progressive Supranuclear Palsy (PSP), Two Months Ahead of Schedule

wn.com - 21/Oct 13:50

This is a randomized, double-blind, placebo-controlled Phase II clinical trial designed to evaluate the efficacy, safety, and pharmacokinetics of...

Heavy drinking fuels Alzheimer’s disease by igniting brain inflammation and protein damage

news.medical.net - 20/Oct 23:03

Chronic alcohol use accelerates Alzheimer’s disease (AD) progression by intensifying oxidative stress, neuroinflammation, and amyloid-tau pathology...

Sorry! Image not available at this time

Trend Seen for Improved Recurrence-Free Survival With Pembrolizumab in Merkel Cell Carcinoma

drugs.com - 23/Oct 16:10

THURSDAY, Oct. 23, 2025 -- For patients with resected Merkel cell carcinoma (MCC), adjuvant pembrolizumab yields a trend toward improved...

Uncovering mechanisms of neuronal migration in the adult brain

news.medical.net - 28/Oct 19:14

Researchers have discovered how newly created neurons depend on blood flow in the adult brain to travel from their site of origin to their final...